Cybin(CYBN) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sunrun, HubSpot, Rocket, Summit, Cybin: Trending by Analysts
TipRanksMar 15 05:02 ET · Ratings
Cybin Price Target Announced at $35.00/Share by Guggenheim
Dow JonesMar 13 11:33 ET · Ratings
Guggenheim Initiates Cybin(CYBN.US) With Buy Rating, Announces Target Price $35
Moomoo NewsMar 12 18:31 ET · Ratings
Express News | 'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
BenzingaMar 12 11:45 ET
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
TipRanksMar 10 23:52 ET
Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025
Yahoo FinanceMar 1 10:56 ET

Comments

Jaguar8

Mar 28 06:17

🟠Watchlist, MARCH 28,2025, Friday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If y...

43

9

2

Jaguar8

Mar 27 06:55

⚫️Watchlist, MARCH 27,2025, Thursday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...

47

6

2

Arrayfunction

Mar 14 05:36

Might wanna pump the brakes a bit (Schedule I drug challenges)

I saw a large part of the $Cybin (CYBN.US)$ hype being to replace Spravato (S-ketamine). Here are a few things to consider in good ol' Peter Lynch style
1) Spravato (S-ketamine) is only a schedule III drug. Despite this, the REMS program that a provider must comply with is a giant pain in the ass.
2) Insurance companies are even a bigger pain in the ass about Spravato. It took over a year of arguing to get my coverage (a few months si...

7

3